Diafyt is a certified medical app that utilizes artificial intelligence to calculate insulin dosages for individuals with Type 1 diabetes, helping to minimize the risks of hyperglycemia and hypoglycemia. By learning each user's insulin needs, the app provides tailored dosage recommendations while allowing users to maintain control over their treatment decisions.
Funding
$18.2K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Individuals with Type 1 diabetes face the constant challenge of calculating appropriate insulin dosages to manage blood glucose levels, which can be complex and prone to errors, leading to hyperglycemia or hypoglycemia. Traditional methods and tools may not always provide personalized or accurate recommendations, increasing the risk of adverse health outcomes.
Solution
Diafyt is a certified medical application that leverages artificial intelligence to assist individuals with Type 1 diabetes in determining insulin dosages. The application learns individual insulin needs over time, providing tailored dosage suggestions to minimize the risk of both hyperglycemia and hypoglycemia. Users input meal information, and the AI calculates a recommended insulin dose, offering a decision support tool while empowering users to retain control over their treatment decisions. The app aims to improve glycemic control and HbA1c levels through personalized and intelligent dosage recommendations.
Target Audience
The primary target audience is individuals with Type 1 diabetes who require assistance with insulin dosage calculations and are looking for a personalized, AI-driven solution to improve their glycemic control.
Features
- AI-powered insulin dosage calculation based on individual user data and learning algorithms.
- Personalized dosage recommendations to minimize the risk of hyperglycemia and hypoglycemia.
- Meal logging feature for users to input relevant dietary information.
- Continuous learning and adaptation to individual insulin needs over time.
- Certified medical device ensuring safety, reliability, and data protection.